Overview
Status
Active
Registry date
2023-07-07
Share capital
40,000.00 PLN
Registered address
26, 62-600 Czołowo-Kolonia, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 2 days early.
- 202515/07/2026
- 202411/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 535.09kMedianUSD 287.80kAverageUSD 4.90m
Net profit
This companyUSD 111.32kMedianUSD 12.59kAverageUSD 208.64k
Operating costs
This companyUSD 410.09kMedianUSD 272.78kAverageUSD 4.48m
Assets
This companyUSD 308.34kMedianUSD 224.38kAverageUSD 5.76m
Industry
Authorized Representatives
Andrzej Kubacki – Management Board Member
Łukasz Kubacki – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Kubackiage 71 | 400 | $5,402.49 | 50% |
Łukasz Kubackiage 47 | 400 | $5,402.49 | 50% |
Andrzej Kubacki and Łukasz Kubacki hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BrasterS.A. | $575,370.12 | braster.eu | ||
| Hexdent Labsp. z o.o. | $636,563.46 | hexdentlab.pl | ||
| Ortegosp. z o.o. | $635,362.52 | ortego.pl | ||
| Nexon Pharmasp. z o.o. + limited partnership | $631,778.22 | nexonpharma.pl | ||
| String Polskasp. z o.o. | $619,207.94 | string.com.pl | ||
| Horyzont Optyksp. z o.o. | $478,713.69 | horyzontoptyk.com.pl | ||
| Salon Ortopedyczny Or-Techsp. z o.o. | $453,978.03 | or-tech.pl | ||
| Vbionicsp. z o.o. | $283,497.72 | vbionic.com | ||
| Exacto Labsp. z o.o. | $260,654.48 | exactolab.pl | ||
| Pinklabsp. z o.o. | $221,273.55 | pinklab.pl |
FAQ
The main business activity of Radent focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on July 7, 2023.
The headquarters is located at: 26, 62-600 Czołowo-Kolonia.
The share capital of the company is PLN 40,000 (approx. $10,805).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 535,090, representing a decrease of 28.8% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 111,322, meaning the company decreased its profit by 34.2%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 242,217 in 2025, representing 59% of all operating expenses.
Last updated: 2026-10-13
